Performance of matrix-based risk models for rapid radiographic progression in a cohort of patients with established rheumatoid arthritis

Arthritis Care and Research

Volumn 65, Issue 4, 2013, Pages 526-533

  Lillegraven, Siri ^a,b   Paynter, Nina ^a   Prince, Femke H M ^a   Shadick, Nancy A ^a   Haavardsholm, Espen A ^b   Frits, Michelle L ^a   Iannaccone, Christine K ^a   Kvien, Tore K ^b   Weinblatt, Michael E ^a   Solomon, Daniel H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DIAKONHJEMMET HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; HYDROXYCHLOROQUINE; INFLIXIMAB; METHOTREXATE; SALAZOSULFAPYRIDINE;

AGED; ARTICLE; COHORT ANALYSIS; DISEASE DURATION; FEMALE; HAND RADIOGRAPHY; HUMAN; JOINT SWELLING; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PERFORMANCE; PREDICTOR VARIABLE; RADIOLOGICAL PARAMETERS; RAPID RADIOGRAPHIC PROGRESSION; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK MODEL MATRIX; STATISTICAL MODEL;

AGED; ARTHRITIS, RHEUMATOID; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 84875691200     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.21870     Document Type: Article

References (20)

1. Scott DL, Wolfe F, Huizinga TW,. Rheumatoid arthritis. Lancet 2010; 376: 1094-108.
2. Visser K, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Ronday HK, Seys PE, Kerstens PJ, et al. A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt study. Ann Rheum Dis 2010; 69: 1333-7.
3. Vastesaeger N, Xu S, Aletaha D, St. Clair EW, Smolen JS,. A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis. Rheumatology (Oxford) 2009; 48: 1114-21.
4. Engstrom A, Saevarsdottir S, Rezaei H, Geborek P, Petersson I, Ernestam S, et al. Development of a matrix risk model for prediction of rapid radiographic progression based on the SWEFOT trial population [abstract]. Ann Rheum Dis 2011; 70 Suppl: 77.
5. Durnez A, Vanderschueren G, Lateur L, Westhovens R, Verschueren P,. Effectiveness of initial treatment allocation based on expert opinion for prevention of rapid radiographic progression in daily practice of an early RA cohort. Ann Rheum Dis 2011; 70: 634-7.
6. Saevarsdottir S, Wallin H, Seddighzadeh M, Ernestam S, Geborek P, Petersson IF, et al. Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial. Ann Rheum Dis 2011; 70: 469-75.
7. Vastesaeger N, van der Heijde D, Inman RD, Wang Y, Deodhar A, Hsu B, et al. Predicting the outcome of ankylosing spondylitis therapy. Ann Rheum Dis 2011; 70: 973-81.
8. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB,. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-47.
9. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987-1003.
10. Pencina MJ, D'Agostino RB Sr, Steyerberg EW,. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 2011; 30: 11-21.
11. Pencina MJ, D'Agostino RB, Vasan RS,. Statistical methods for assessment of added usefulness of new biomarkers. Clin Chem Lab Med 2010; 48: 1703-11.
12. Cook NR, Ridker PM,. Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures. Ann Intern Med 2009; 150: 795-802.
13. Ridker PM, Buring JE, Rifai N, Cook NR,. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 2007; 297: 611-9.
14. Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 2010; 21: 128-38.
15. Iannaccone CK, Lee YC, Cui J, Frits ML, Glass RJ, Plenge RM, et al. Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study. Rheumatology (Oxford) 2011; 50: 40-6.
16. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
17. Van der Heijde D,. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 2000; 27: 261-3.
18. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS,. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27: 157-72.
19. Janes H, Pepe MS, Gu W,. Assessing the value of risk predictions by using risk stratification tables. Ann Intern Med 2008; 149: 751-60.
20. Felson DT, Smolen JS, Wells G, Zhang B, van Tuyl LH, Funovits J, et al. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum 2011; 63: 573-86.